Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
JPMorgan Chase & Co. and its affiliates have emerged as a substantial holder in Clinuvel Pharmaceuticals Limited, with a 5.49% stake consisting of 2,747,088 ordinary shares as of 26 July 2024. The shares are held through various subsidiaries and include securities on loan and those subject to obligations to return under securities lending agreements.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
